Cysal GmbH produces arginyl-aspartate and lysyl-aspartate (dipeptides) on an industrial scale by means of an internationally patented biotechnological process. The biotechnological company uses these dipeptides, i.e. the bond of two amino acids, as a basis for the production of specially developed end products such as energy tonics, skin creams, animal feed or infusion agents. In addition Cysal licences its technology to relevant industrial corporates.
Location: Germany, North Rhine-Westphalia, Münster
Investors 2
Date | Name | Website |
- | eCAPITAL | ecapital.v... |
- | High-Tech ... | htgf.de |
Mentions in press and media 1
Date | Title | Description | Source |
08.11.2012 | Cysal Receives Seven Figure Seed Financing | Cysal GmbH, a Münster, Germany-based biotechnology company, has received a seven-figure seed financi... | finsmes.co... |